Skip to main content
Erschienen in: Journal of Neuro-Oncology 3/2018

01.12.2017 | Clinical Study

Characteristics of cerebellar glioblastomas in adults

verfasst von: Thiébaud Picart, Marc Barritault, Julien Berthillier, David Meyronet, Alexandre Vasiljevic, Didier Frappaz, Jérôme Honnorat, Emmanuel Jouanneau, Delphine Poncet, François Ducray, Jacques Guyotat

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Adult cerebellar glioblastomas (cGBM) are rare and their characteristics remain to be fully described. We analyzed the characteristics of 17 adult patients with cGBM and compared them to a series of 103 patients presenting a supra-tentorial glioblastoma (stGBM). The mean age at GBMc diagnosis was 53.4 years (range 28–77). A history of neurofibromatosis type I was noted in 3 patients. cGBM were hemispheric in 10 patients (58.8%), only vermian in 4 patients (23.5%), and both vermian and hemispheric in 3 patients (17.7%). A H3 K27M mutation was identified in 3/14 patients, a TERT promoter mutation in 3/14 patients and a methylated MGMT promoter in 3/14 patients. None of the patients (0/14) harbored an EGFR amplification, an IDH or a BRAF mutation. Association with neurofibromatosis type I and H3K27M mutations were mutually exclusive. Compared with stGBM, cGBM occurred in younger patients (53.4 vs. 63.2, p = 0.02), were more frequently associated with neurofibromatosis type I (18 vs. 1%, p = 0.009) and with a H3 K27M mutation (21 vs. 3%, p = 0.02). They also tended to have a more frequent multifocal presentation at diagnosis (21 vs. 4.3%, p = 0.06), more frequently resulted in leptomeningeal or intra-axial metastasis (44.5 vs. 5%, p = 0.002) and were associated with a shorter median overall survival (5.9 vs. 14.2 months, p = 0.004). The present study suggests that adult cGBM differ from their supra-tentorial counterpart and constitute a heterogeneous group of IDH wild-type gliomas with at least two subgroups, one associated with H3K27M mutations and the other with neurofibromatosis type I.
Literatur
1.
Zurück zum Zitat Chamberlain MC, Silver P, Levin VA (1990) Poorly differentiated gliomas of the cerebellum. A study of 18 patients. Cancer 65:337–340CrossRefPubMed Chamberlain MC, Silver P, Levin VA (1990) Poorly differentiated gliomas of the cerebellum. A study of 18 patients. Cancer 65:337–340CrossRefPubMed
2.
Zurück zum Zitat Bi WL, Chiocca EA (2013) Adult cerebellar glioblastomas: a distinct entity or parcel of the whole? World Neurosurg 80(6):181–183CrossRef Bi WL, Chiocca EA (2013) Adult cerebellar glioblastomas: a distinct entity or parcel of the whole? World Neurosurg 80(6):181–183CrossRef
3.
Zurück zum Zitat Mattos JP, Marenco HA, Campos JM et al (2006) Cerebellar glioblastoma multiforme in an dult. Arq Neuropsiquiatr 64(1):132–135CrossRefPubMed Mattos JP, Marenco HA, Campos JM et al (2006) Cerebellar glioblastoma multiforme in an dult. Arq Neuropsiquiatr 64(1):132–135CrossRefPubMed
4.
Zurück zum Zitat Levine SA, McKeever PE, Greenberg HS (1987) Primary cerebellar glioblastoma multiforme. J Neuro-Oncology 5:231–236CrossRef Levine SA, McKeever PE, Greenberg HS (1987) Primary cerebellar glioblastoma multiforme. J Neuro-Oncology 5:231–236CrossRef
5.
Zurück zum Zitat Adams H, Chaichana KL, Avendaño J et al (2013) Adult cerebellar glioblastoma: understanding survival and prognostic factors using a population-based database from 1973 to 2009. World Neurosurg 80(6):237–243CrossRef Adams H, Chaichana KL, Avendaño J et al (2013) Adult cerebellar glioblastoma: understanding survival and prognostic factors using a population-based database from 1973 to 2009. World Neurosurg 80(6):237–243CrossRef
6.
Zurück zum Zitat Akimoto J, Fukami S, Tsutsumi M et al (2009) Radiopathological characteristics of cerebellar malignant glioma in adults. Brain Tumor Pathol 26:59CrossRefPubMed Akimoto J, Fukami S, Tsutsumi M et al (2009) Radiopathological characteristics of cerebellar malignant glioma in adults. Brain Tumor Pathol 26:59CrossRefPubMed
7.
Zurück zum Zitat Babu R, Sharma R, Karikari IO et al (2013) Outcome and prognostic factors in adult cerebellar glioblastoma. J Clin Neurosci 20(8):1117–1121CrossRefPubMed Babu R, Sharma R, Karikari IO et al (2013) Outcome and prognostic factors in adult cerebellar glioblastoma. J Clin Neurosci 20(8):1117–1121CrossRefPubMed
8.
Zurück zum Zitat Gopalakrishnan CV, Dhakoji A, Nair S et al (2012) A retrospective study of primary cerebellar glioblastoma multiforme in adults. J Clin Neurosci 19(12):1684–1688CrossRefPubMed Gopalakrishnan CV, Dhakoji A, Nair S et al (2012) A retrospective study of primary cerebellar glioblastoma multiforme in adults. J Clin Neurosci 19(12):1684–1688CrossRefPubMed
9.
Zurück zum Zitat Grahovac G, Tomac D, Lambasa S et al (2009) Cerebellar glioblastomas: pathophysiology, clinical presentation and management. Acta Neurochir 151(6):653–657CrossRefPubMed Grahovac G, Tomac D, Lambasa S et al (2009) Cerebellar glioblastomas: pathophysiology, clinical presentation and management. Acta Neurochir 151(6):653–657CrossRefPubMed
10.
Zurück zum Zitat Gupta V, Goyal A, Sinha S et al (2003) Glioblastoma of the cerebellum. A report of 3 cases. J Neurosurg Sci 47(3):157–164PubMed Gupta V, Goyal A, Sinha S et al (2003) Glioblastoma of the cerebellum. A report of 3 cases. J Neurosurg Sci 47(3):157–164PubMed
11.
Zurück zum Zitat Hur H, Jung S, Jung TY et al (2008) Cerebellar glioblastoma multiforme in an adult? J Korean Neurosurg 43:194–197CrossRef Hur H, Jung S, Jung TY et al (2008) Cerebellar glioblastoma multiforme in an adult? J Korean Neurosurg 43:194–197CrossRef
13.
Zurück zum Zitat Lakičević G, Arnautović K, Mužević D et al (2014) Cerebellar glioblastoma multiforme presenting as hypertensive cerebellar hemorrhage: case report. J Neurol Surg Rep 75(1):e117–e121CrossRefPubMedPubMedCentral Lakičević G, Arnautović K, Mužević D et al (2014) Cerebellar glioblastoma multiforme presenting as hypertensive cerebellar hemorrhage: case report. J Neurol Surg Rep 75(1):e117–e121CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Linsenmann T, Monoranu CM, Vince GH et al (2014) Long-term tumor control of spinal dissemination of cerebellar glioblastoma multiforme by combined adjuvant bevacizumab antibody therapy: a case report. BMC Res Notes 7:496CrossRefPubMedPubMedCentral Linsenmann T, Monoranu CM, Vince GH et al (2014) Long-term tumor control of spinal dissemination of cerebellar glioblastoma multiforme by combined adjuvant bevacizumab antibody therapy: a case report. BMC Res Notes 7:496CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Miller EM, Mani RL, Townsend JJ (1976) Cerebellar glioblastoma multiforme in an adult. Surg Neurol 5(6):341–343PubMed Miller EM, Mani RL, Townsend JJ (1976) Cerebellar glioblastoma multiforme in an adult. Surg Neurol 5(6):341–343PubMed
16.
17.
Zurück zum Zitat Saito T, Hama S, Kajiwara Y et al (2006) Prognosis of cerebellar glioblastomas: correlation between prognosis and immunoreactivity for epidermal growth factor receptor compared with supratentorial glioblastomas. Anticancer Res 26:1351–1358PubMed Saito T, Hama S, Kajiwara Y et al (2006) Prognosis of cerebellar glioblastomas: correlation between prognosis and immunoreactivity for epidermal growth factor receptor compared with supratentorial glioblastomas. Anticancer Res 26:1351–1358PubMed
19.
Zurück zum Zitat Stark AAM, Maslehaty H, Hugo HH et al (2010) Glioblastoma of the cerebellum and brainstem. J Clin Neurosci 17:1248–1251CrossRefPubMed Stark AAM, Maslehaty H, Hugo HH et al (2010) Glioblastoma of the cerebellum and brainstem. J Clin Neurosci 17:1248–1251CrossRefPubMed
20.
Zurück zum Zitat Tamaki T, Eguchi T, Sakamoto M et al (2004) Glioblastoma multiforme of the cerebellum in an elderly man. J Chin Med Assoc 67(6):301–304PubMed Tamaki T, Eguchi T, Sakamoto M et al (2004) Glioblastoma multiforme of the cerebellum in an elderly man. J Chin Med Assoc 67(6):301–304PubMed
21.
Zurück zum Zitat Tsung AJ, Prabhu SS, Lei X et al (2011) Cerebellar glioblastoma: a retrospective review of 21 patients at a single institution. J Neurooncol 105:555–562CrossRefPubMed Tsung AJ, Prabhu SS, Lei X et al (2011) Cerebellar glioblastoma: a retrospective review of 21 patients at a single institution. J Neurooncol 105:555–562CrossRefPubMed
22.
Zurück zum Zitat Weber DC, Miller RC, Villà S et al (2006) Outcome and prognosis factors in cerebellar glioblastoma multiforme in adults: a retrospective study from the rare cancer network. Int J Radiat Oncol Biol Phys 1 66(1):179–186CrossRefPubMed Weber DC, Miller RC, Villà S et al (2006) Outcome and prognosis factors in cerebellar glioblastoma multiforme in adults: a retrospective study from the rare cancer network. Int J Radiat Oncol Biol Phys 1 66(1):179–186CrossRefPubMed
24.
Zurück zum Zitat Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963–1972CrossRefPubMed Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963–1972CrossRefPubMed
25.
Zurück zum Zitat Meyronet D, Esteban-Mader M, Bonnet C et al (2017) Characteristics of H3 K27M-mutant gliomas in adults. Neuro-Oncology. 19:1127CrossRefPubMed Meyronet D, Esteban-Mader M, Bonnet C et al (2017) Characteristics of H3 K27M-mutant gliomas in adults. Neuro-Oncology. 19:1127CrossRefPubMed
26.
Zurück zum Zitat Walter T, van Brakel B, Vercherat C et al (2015) O6-methylguanine-DNA methyltransferase status in neuroendocrine tumours: prognostic relevance and association with response to alkylating agents. Br J Cancer 112(3):523–531CrossRefPubMedPubMedCentral Walter T, van Brakel B, Vercherat C et al (2015) O6-methylguanine-DNA methyltransferase status in neuroendocrine tumours: prognostic relevance and association with response to alkylating agents. Br J Cancer 112(3):523–531CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Idbaih A, Criniere E, Marie Y et al (2008) Gene amplification is a poor prognostic factor in anaplastic oligodendrogliomas. Neuro-Oncology 10(4):540–547CrossRefPubMedPubMedCentral Idbaih A, Criniere E, Marie Y et al (2008) Gene amplification is a poor prognostic factor in anaplastic oligodendrogliomas. Neuro-Oncology 10(4):540–547CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Takahashi Y, Makino K, Nakamura H et al (2014) Clinical characteristics and pathogenesis of cerebellar glioblastoma. Mol Med Rep 10(5):2383–2388CrossRefPubMed Takahashi Y, Makino K, Nakamura H et al (2014) Clinical characteristics and pathogenesis of cerebellar glioblastoma. Mol Med Rep 10(5):2383–2388CrossRefPubMed
29.
Zurück zum Zitat Kuroiwa T, Numaguchi Y, Rothman MI et al (1995) Posterior fossa glioblastoma multiforme: MR findings. Am J Neuroradiol 16:583–589PubMed Kuroiwa T, Numaguchi Y, Rothman MI et al (1995) Posterior fossa glioblastoma multiforme: MR findings. Am J Neuroradiol 16:583–589PubMed
30.
Zurück zum Zitat Utsuki S, Oka H, Miyajima Y et al (2012) Adult cerebellar glioblastoma cases have different characteristics from supratentorial glioblastoma. Brain Tumor Pathol 29(2):87–95CrossRefPubMed Utsuki S, Oka H, Miyajima Y et al (2012) Adult cerebellar glioblastoma cases have different characteristics from supratentorial glioblastoma. Brain Tumor Pathol 29(2):87–95CrossRefPubMed
31.
Zurück zum Zitat Kulkarni AV, Becker LE, Jay V et al (1999) Primary cerebellar glioblastomas multiforme in children. Report of four cases. J Neurosurg 90(3):546–550CrossRefPubMed Kulkarni AV, Becker LE, Jay V et al (1999) Primary cerebellar glioblastomas multiforme in children. Report of four cases. J Neurosurg 90(3):546–550CrossRefPubMed
32.
Zurück zum Zitat Zito JL, Siva A, Smith TW et al (1983) Glioblastoma of the cerebellum. Computed tomographic and pathologic considerations. Surg Neurol 19(4):373–378CrossRefPubMed Zito JL, Siva A, Smith TW et al (1983) Glioblastoma of the cerebellum. Computed tomographic and pathologic considerations. Surg Neurol 19(4):373–378CrossRefPubMed
33.
Zurück zum Zitat Pato-Pato A, Cimas-Hernando I, Lorenzo-González JR et al (2004) Cerebellar glioblastoma multiforme: a case report. Rev Neurol 38(9):839–842PubMed Pato-Pato A, Cimas-Hernando I, Lorenzo-González JR et al (2004) Cerebellar glioblastoma multiforme: a case report. Rev Neurol 38(9):839–842PubMed
34.
Zurück zum Zitat Lobão CAF, Barbosa AS, Nogueira J et al (2008) Cerebellar glioblastoma mutiforme in an adult. Arq Neuropsiquiatr 66(4):879–880CrossRefPubMed Lobão CAF, Barbosa AS, Nogueira J et al (2008) Cerebellar glioblastoma mutiforme in an adult. Arq Neuropsiquiatr 66(4):879–880CrossRefPubMed
35.
Zurück zum Zitat Singla N, Kapoor A, Savardekar A et al (2016) Malignant cerebellar peduncle lesions - rapid progression and poor outcome. Surg Neurol Int 7:S170–S173CrossRefPubMedPubMedCentral Singla N, Kapoor A, Savardekar A et al (2016) Malignant cerebellar peduncle lesions - rapid progression and poor outcome. Surg Neurol Int 7:S170–S173CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Sturm D, Witt H, Hovestadt V et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22(4):425–437CrossRefPubMed Sturm D, Witt H, Hovestadt V et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22(4):425–437CrossRefPubMed
37.
Zurück zum Zitat Kawarabuki K, Ohta T, Hashimoto N et al (2005) Cerebellar glioblastoma genetically defined as a secondary one. Clin Neuropathol 24(2):64–68PubMed Kawarabuki K, Ohta T, Hashimoto N et al (2005) Cerebellar glioblastoma genetically defined as a secondary one. Clin Neuropathol 24(2):64–68PubMed
38.
Zurück zum Zitat Yang SY, Wang KC, Cho BK et al (2005) Radiation-induced cerebellar glioblastoma at the site of a treated medulloblastoma: case report. J Neurosurg 102(4 Suppl):417–422PubMed Yang SY, Wang KC, Cho BK et al (2005) Radiation-induced cerebellar glioblastoma at the site of a treated medulloblastoma: case report. J Neurosurg 102(4 Suppl):417–422PubMed
39.
Zurück zum Zitat Ceccarelli M, Barthel FP, Malta TM et al (2016) Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell 164(3):550–563CrossRefPubMedPubMedCentral Ceccarelli M, Barthel FP, Malta TM et al (2016) Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell 164(3):550–563CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Gerrit H, Gielen M, Gessi J, Hammes et al (2013) H3F3A K27M mutation in pediatric CNS tumors: a marker for diffuse high-grade astrocytoma. Am J Clin Pathol 139(3):345–349CrossRef Gerrit H, Gielen M, Gessi J, Hammes et al (2013) H3F3A K27M mutation in pediatric CNS tumors: a marker for diffuse high-grade astrocytoma. Am J Clin Pathol 139(3):345–349CrossRef
42.
Zurück zum Zitat Aboian MS, Solomon DA, Felton E et al (2017) Imaging characteristics of pediatric diffuse midline gliomas with histone H3 K27M mutation. Am J Neuroradiol 38(4):795–800CrossRefPubMedPubMedCentral Aboian MS, Solomon DA, Felton E et al (2017) Imaging characteristics of pediatric diffuse midline gliomas with histone H3 K27M mutation. Am J Neuroradiol 38(4):795–800CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Venneti S, Santi M, Felicella MM et al (2014) A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas. Acta Neuropathol 128(5):743–753CrossRefPubMedPubMedCentral Venneti S, Santi M, Felicella MM et al (2014) A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas. Acta Neuropathol 128(5):743–753CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Reyes-Botero G, Giry M, Mokhtari K et al (2014) Molecular analysis of diffuse intrinsic brainstem gliomas in adults. J Neurooncol 116(2):405–411CrossRefPubMed Reyes-Botero G, Giry M, Mokhtari K et al (2014) Molecular analysis of diffuse intrinsic brainstem gliomas in adults. J Neurooncol 116(2):405–411CrossRefPubMed
47.
Zurück zum Zitat Guillamo JS, Créange A, Kalifa C et al (2003) Prognostic factors of CNS tumours in neurofibromatosis 1 (NF1): a retrospective study of 104 patients. Brain 126(Pt 1):152–160CrossRefPubMed Guillamo JS, Créange A, Kalifa C et al (2003) Prognostic factors of CNS tumours in neurofibromatosis 1 (NF1): a retrospective study of 104 patients. Brain 126(Pt 1):152–160CrossRefPubMed
48.
Zurück zum Zitat Vizcaíno MA, Shah S, Eberhart CG et al (2015) Clinicopathologic implications of NF1 gene alterations in diffuse gliomas. Hum Pathol 46(9):1323–1330CrossRefPubMedPubMedCentral Vizcaíno MA, Shah S, Eberhart CG et al (2015) Clinicopathologic implications of NF1 gene alterations in diffuse gliomas. Hum Pathol 46(9):1323–1330CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat Aihara K, Mukasa A, Gotoh K et al (2014) H3F3A K27M mutations in thalamic gliomas from young adult patients. Neuro-Oncology 16(1):140–146CrossRefPubMed Aihara K, Mukasa A, Gotoh K et al (2014) H3F3A K27M mutations in thalamic gliomas from young adult patients. Neuro-Oncology 16(1):140–146CrossRefPubMed
50.
Zurück zum Zitat Ameratunga M, McArthur G, Gan H et al (2016) Prolonged disease control with MEK inhibitor in neurofibromatosis type I-associated glioblastoma. J Clin Pharm Ther 41(3):357–359CrossRefPubMed Ameratunga M, McArthur G, Gan H et al (2016) Prolonged disease control with MEK inhibitor in neurofibromatosis type I-associated glioblastoma. J Clin Pharm Ther 41(3):357–359CrossRefPubMed
51.
Zurück zum Zitat Vanan MI, Underhill DA, Eisenstat DD (2017) Targeting epigenetic pathways in the treatment of pediatric Diffuse (high grade) gliomas. Neurotherapeutics 14(2):274–283CrossRefPubMed Vanan MI, Underhill DA, Eisenstat DD (2017) Targeting epigenetic pathways in the treatment of pediatric Diffuse (high grade) gliomas. Neurotherapeutics 14(2):274–283CrossRefPubMed
Metadaten
Titel
Characteristics of cerebellar glioblastomas in adults
verfasst von
Thiébaud Picart
Marc Barritault
Julien Berthillier
David Meyronet
Alexandre Vasiljevic
Didier Frappaz
Jérôme Honnorat
Emmanuel Jouanneau
Delphine Poncet
François Ducray
Jacques Guyotat
Publikationsdatum
01.12.2017
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 3/2018
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-017-2682-7

Weitere Artikel der Ausgabe 3/2018

Journal of Neuro-Oncology 3/2018 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.